InventisBio outlicenses D0316\'s right in China to Betta Pharma

InventisBio out─licenses D─0316's right in China to Betta Pharma

12:49 EST 31 Dec 2018 | PharmaBiz

InventisBio, a fast growing, clinical stage biotech company, has signed a collaboration agreement with Betta Pharma.

Original Article: InventisBio out─licenses D─0316's right in China to Betta Pharma

More From BioPortfolio on "InventisBio out─licenses D─0316's right in China to Betta Pharma"